SOPHiA GENETICS SA - Ordinary Shares (SOPH)
Technology › Services-Computer Processing & Data Preparation
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- P/B of 7.26 — trading above book value
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -167.6%
- Revenue growing at 19% annually
SOPHiA GENETICS SA - Ordinary Shares (SOPH) is a Technology company operating in Services-Computer Processing & Data Preparation, listed on the NASDAQ , with a market capitalisation of $342 million . Key value metrics: P/B ratio 7.26, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
SOPHiA GENETICS SA - Ordinary Shares — Fundamental Analysis Summary
On financial health, SOPH shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -167.6% (sector average: -1.0%), and high leverage with a debt-to-equity ratio of 2.46.
StockPik's composite Value Score for SOPH is 32/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SOPH reports a high gross margin of 67.4% (sector average: 40.2%) and a negative operating margin of -91.8%.
SOPH shows revenue growing at 19% year-over-year, with earnings declining at 26%.